Fulgent Genetics, Inc. (FLGT) › Capital ExpendituresFulgent Genetics, Inc. (FLGT) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2014: $731.0K2015: $2.10M2016: $3.79M2017: $2.90M2018: $2.32M2019: $1.18M2020: $35.13M2021: $23.81M2022: $18.77M2023: $22.21M2024: $40.31M2025: $22.57M$22.57M2014Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$22.57M-44.0%2024$40.31M+81.5%2023$22.21M+18.3%2022$18.77M-21.2%2021$23.81M-32.2%2020$35.13M+2872.1%2019$1.18M-49.1%2018$2.32M-19.8%2017$2.90M-23.6%2016$3.79M+80.4%2015$2.10M+187.3%2014$731.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share